# Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer

> **NCT02070432** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Luzitin SA** · enrollment: 20 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** LUZ11

## Key facts

- **NCT ID:** NCT02070432
- **Lead sponsor:** Luzitin SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070432, "Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02070432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*